We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bar Harbor BioTechnology Announces Launch of new Diagnostic Division
News

Bar Harbor BioTechnology Announces Launch of new Diagnostic Division

Bar Harbor BioTechnology Announces Launch of new Diagnostic Division
News

Bar Harbor BioTechnology Announces Launch of new Diagnostic Division

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Bar Harbor BioTechnology Announces Launch of new Diagnostic Division"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Bar Harbor BioTechnology has announced plans to launch a new division focused on molecular diagnostics and personalized medicine. This new division will create genetic diagnostic tests that determine an individual's risk of developing a disease.

In 2009 the company made a breakthrough using its technology that allowed it to generate a statistical prediction of a person's susceptibility of developing a disease. The first test will be for colorectal cancer and is scheduled to be completed in January 2011.

Robert Phelps, CEO of Bar Harbor BioTechnology, says the company has already started work on similar tests for Alzheimer's disease, Prostate Cancer and Lupus. He stated that the company has contacted the FDA seeking guidance regarding the manufacturing of these new tests and plans to work closely with the agency as new regulations are being developed for the genetic testing market. For now the company is reviewing its financial options to fund the new division which has a long term goal of creating a federally certified laboratory to conduct these tests for point of care physicians.
Advertisement